Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: A useful means of identifying thyroglobulin assay interference

Annals of Clinical Biochemistry

Volumn 50, Issue 5, 2013, Pages 421-432

  Crane, Michael S ^a   Strachan, Mark W J ^a   Toft, Anthony D ^a   Beckett, Geoffrey J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Differentiated thyroid cancer; Immunometric assay; Radioimmunoassay; Thyroglobulin

Indexed keywords

THYROGLOBULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOMETRIC ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT MONITORING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECURRENT CANCER; THYROGLOBULIN BLOOD LEVEL;

EID: 84890138496     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213480492     Document Type: Article

References (25)

1. British Thyroid Association. Guidelines for the Management of Thyroid Cancer. 2nd edn. London: Royal College of Physicians, 2007
2. Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214
3. Giovanella L and Ghelfo A. Undetectable serum thyroglobulin due to negative interference of heterophile antibodies in relapsing thyroid carcinoma. Clin Chem 2007; 53: 1871-2
4. Preissner CM, O'Kane DJ, Singh RJ, Morris JC and Grebe SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003; 88: 3069-74
5. Spencer CA, Takeuchi M and Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996; 42: 164-73
6. Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 2004; 89: 3702-4
7. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S and LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005; 90: 5566-75
8. Clark P and Franklyn J. Can we interpret serum thyroglobulin results? Ann Clin Biochem 2012; 49: 313-22
9. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121-7
10. Verburg FA, Waschle K, Reiners C, Giovanella L and Lentjes EG. Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res 2010; 42: 736-9
11. Spencer C, Petrovic I and Fatemi S. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/ undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 2011; 96: 1283-91
12. Pickett AJ, Jones M and Evans C. Causes of discordance between thyroglobulin antibody assays. Ann Clin Biochem 2012; 49: 463-7
13. Massart C and Maugendre D. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease. Clin Chem 2002; 48: 102-7
14. Schneider AB and Pervos R. Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 1978; 47: 126-37
15. Hoofnagle AN, Becker JO, Wener MH and Heinecke JW. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008; 54: 1796-804
16. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99
17. Black EG, Cassoni A, Gimlette TM, et al. Serum thyroglobulin in thyroid cancer. Lancet 1981; 2: 443-5
18. Weightman DR, Mallick UK, Fenwick JD and Perros P. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up. Cancer 2003; 98: 41-7
19. Yamamoto K, Tsuji T, Tarutani O and Osawa T. Structural changes of carbohydrate chains of human thyroglobulin accompanying malignant transformations of thyroid glands. Eur J Biochem 1984; 143: 133-44
20. Iervasi A, Iervasi G, Carpi A and Zucchelli GC. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact. Biomed Pharmacother 2006; 60: 414-24
21. Giovanella L, Ceriani L and Maffioli M. Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma. Head Neck 2010; 32: 568-71
22. Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003; 139: 346-51
23. Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 2011; 96: 3615-27
24. Kim WG, Yoon JH, Kim WB, et al. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2008; 93: 4683-9
25. Okosieme OE, Evans C, Moss L, Parkes AB, Premawardhana LD and Lazarus JH. Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem 2005; 51: 729-34.